Plasmepsin-2

Details

Name
Plasmepsin-2
Synonyms
  • 3.4.23.39
  • Aspartic hemoglobinase II
  • PFAPD
Gene Name
Not Available
Organism
Plasmodium falciparum
Amino acid sequence
>lcl|BSEQ0003359|Plasmepsin-2
MDITVREHDFKHGFIKSNSTFDGLNIDNSKNKKKIQKGFQILYVLLFCSVMCGLFYYVYE
NVWLQRDNEMNEILKNSEHLTIGFKVENAHDRILKTIKTHKLKNYIKESVNFLNSGLTKT
NYLGSSNDNIELVDFQNIMFYGDAEVGDNQQPFTFILDTGSANLWVPSVKCTTAGCLTKH
LYDSSKSRTYEKDGTKVEMNYVSGTVSGFFSKDLVTVGNLSLPYKFIEVIDTNGFEPTYT
ASTFDGILGLGWKDLSIGSVDPIVVELKNQNKIENALFTFYLPVHDKHTGFLTIGGIEER
FYEGPLTYEKLNHDLYWQITLDAHVGNIMLEKANCIVDSGTSAITVPTDFLNKMLQNLDV
IKVPFLPFYVTLCNNSKLPTFEFTSENGKYTLEPEYYLQHIEDVGPGLCMLNIIGLDFPV
PTFILGDPFMRKYFTVFDYDNHSVGIALAKKNL
Number of residues
453
Molecular Weight
51489.41
Theoretical pI
5.43
GO Classification
Functions
aspartic-type endopeptidase activity
Components
vacuole
General Function
Aspartic-type endopeptidase activity
Specific Function
Not Available
Pfam Domain Function
Transmembrane Regions
Not Available
Cellular Location
Vacuole
Chromosome Location
Not Available
Locus
Not Available
External Identifiers
ResourceLink
UniProtKB IDP46925
UniProtKB Entry NamePLM2_PLAFA
GenBank Protein ID858754
GenBank Gene IDL10740
General References
  1. Dame JB, Reddy GR, Yowell CA, Dunn BM, Kay J, Berry C: Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol. 1994 Apr;64(2):177-90. [Article]
  2. Silva AM, Lee AY, Gulnik SV, Maier P, Collins J, Bhat TN, Collins PJ, Cachau RE, Luker KE, Gluzman IY, Francis SE, Oksman A, Goldberg DE, Erickson JW: Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10034-9. [Article]
  3. Bernstein NK, Cherney MM, Loetscher H, Ridley RG, James MN: Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from plasmodium falciparum. Nat Struct Biol. 1999 Jan;6(1):32-7. [Article]

Drug Relations

Drug Relations
DrugBank IDNameDrug groupPharmacological action?ActionsDetails
DB02505N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)experimentalunknownDetails
DB03063N-[(2S,3S)-4-[2-[(5S)-3a,4,5,6,7,7a-Hexahydro-1,3-benzodioxol-5-yl]ethyl-[3-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-hydroxy-1-phenylbutan-2-yl]-3,5-dimethoxy-4-phenylmethoxybenzamideexperimentalunknownDetails
DB043734-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-BenzamideexperimentalunknownDetails
DB043783-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-BenzamideexperimentalunknownDetails
DB01218HalofantrineapprovedunknowninhibitorDetails
DB11638Artenimolapproved, experimental, investigationalunknownligandDetails